A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

References

• LewingtonSClarkeRQizilbashNAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet20023601903191312493255
   PubMed Web of Science ®Google Scholar
• EganBMZhaoYAxonRNUS trends in prevalence, awareness, treatment and control of hypertension, 1988–2008JAMA20103032043205020501926
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J2007281462153617562668
   PubMed Web of Science ®Google Scholar
• StaessenJAThijisqLFagardREffects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe TrialJ Hypertens20042284785715126928
   PubMed Web of Science ®Google Scholar
• WeberMAJuliusSKjeldsenSEBlood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trialLancet20043632049205115207957
   PubMed Web of Science ®Google Scholar
• GradmanAHAcevedoCEvolving strategies for the use of combination therapy in hypertensionCurr Hypertens Rep2002434334912217251
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA20022882981299712479763
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding per-indopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• Blood Pressure Lowering Treatment Trialists’ CollaborationEffects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsLancet20033621527153514615107
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive PatientsEffects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm HgJAMA1967202102810344862069
   PubMed Web of Science ®Google Scholar
• GavrasHBrunnerHRThurstonHLaraghJHReciprocation of renin dependency with sodium volume dependency in renal hypertensionScience1975188131613171145199
   PubMed Web of Science ®Google Scholar
• GavrasHBrunnerHBVaughanEDLaraghJHAngiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive ratsScience1973180136913714350930
   PubMed Web of Science ®Google Scholar
• JamersonKABasileJPrompt, aggressive BP lowering in high-risk patientsJ Clin Hypertens (Greenwich)200810404818174783
   PubMed Web of Science ®Google Scholar
• TaylorAAShoheiberOAdherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapyCongest Heart Fail2003932433214688505
   PubMedGoogle Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008592417242819052124
   PubMed Web of Science ®Google Scholar
• BakrisGLWeirMRAchieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approachesJ Clin Hypertens (Greenwich)2003520220912826783
   PubMedGoogle Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet20043632022203115207952
   PubMed Web of Science ®Google Scholar
• CohnJNTognoniGfor the Valsartan Heart Failure Trial InvestigatorsA randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureN Engl J Med20013451667167511759645
   PubMed Web of Science ®Google Scholar
• PfefferMAMcmurrayJJVelazquezEJValsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothN Engl J Med20033491893190614610160
   PubMed Web of Science ®Google Scholar
• PackerMO’ConnorCMGhaliJKEffect of amlodipine on morbidity and mortality in severe chronic heart failureN Engl J Med1996335110711148813041
   PubMed Web of Science ®Google Scholar
• WrightJTJrBakrisGGreeneTEffect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJAMA20022882421243112435255
   PubMed Web of Science ®Google Scholar
• MotwaniJGCombining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertensionJ Renin Angiotensin Aldosterone Syst20023727812228846
   PubMed Web of Science ®Google Scholar
• CalhounDALacourciereYChiangYTGlazerRDTriple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trialHypertension200954323919470877
   PubMed Web of Science ®Google Scholar
• CalhounDACrikelairNAYenJGlazerRDAmlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: secondary analyses evaluating efficacy and safetyAdv Therapy20092610121023
   PubMed Web of Science ®Google Scholar
• FlackJMCalhounDASatlinLEfficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND studyJ Hum Hypertens20092347948919190658
   PubMed Web of Science ®Google Scholar
• WrightRDuprezDYadaoAA valsartan-based antihypertensive regimen is more effective than a losartan-based regimen in patients with stage 2 hypertension: the EXALT study [Abstract]J Clin Hypertens201012533
   Google Scholar
• OparilSMelinoMLeeJTriple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group studyClin Ther20103211820171406
   PubMed Web of Science ®Google Scholar
• ElijovichFLafferCA role for single-pill triple therapy in hypertensionTher Adv Cardiovasc Dis2009323124019443512
   PubMedGoogle Scholar
• CalhounDAJonesDTextorSResistant hypertension: diagnosis, evaluation, and treatment A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure ResearchHypertension2008511403141918391085
   PubMed Web of Science ®Google Scholar
• LafferCLElijovichFEssential hypertension of Caribbean Hispanics: sodium, renin, and response to therapyJ Clin Hypertens (Greenwich)2002426627312147929
   PubMedGoogle Scholar
• WeinbergerMHFinebergNSFinebergSEWeinbergerMSalt sensitivity, pulse pressure, and death in normal and hypertensive humansHypertension20013742943211230313
   PubMed Web of Science ®Google Scholar
• LafferCLLaniado-SchwartzmanMWangMHDifferential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertensionCirculation200310757457812566369
   PubMed Web of Science ®Google Scholar
• LafferCLGainerJVWatermanMRThe T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertensionHypertension20085176777218227405
   PubMed Web of Science ®Google Scholar
• GerbinoPPShoheiberOAdherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agentsAm J Health Syst Pharm2007641279128317563050
   PubMed Web of Science ®Google Scholar